Want to see HK:2219 full AI Analyst Report?
Chaoju Eye Care Holdings Ltd. (2219) AI Stock Analysis
Top Page
Chaoju Eye Care Holdings Ltd.
(HKEX:2219)
The score is supported most by attractive valuation (low P/E and high dividend yield) and a strong, low-leverage balance sheet. These positives are tempered by weaker recent operating trends (2025 revenue decline, margin compression) and notably softer/volatile free cash flow, while technical indicators suggest only modest, neutral-to-slightly-positive momentum.
Chaoju Eye Care Holdings Ltd. (2219) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 1.64B
- Dividend Yield
- 10.27%
- Average Volume (3M)
- 277.82K
- Price to Earnings (P/E)
- 8.3
- Beta (1Y)
- 0.55
- Revenue Growth
- 3.85%
- EPS Growth
- -1.23%
- Country
- Hong Kong
- Employees
- 2,619
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Chaoju Eye Care Holdings Ltd. Business Overview & Revenue Model
Company Description
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia...
How the Company Makes Money
Chaoju Eye Care Holdings generates revenue primarily by providing paid ophthalmic medical services to patients through its hospitals and clinics. Its core revenue streams typically include: (1) surgical and procedure-based services (e.g., refractive...
Chaoju Eye Care Holdings Ltd. Financial Statement Overview
Summary
Overall fundamentals are stable but mixed. Profitability is still solid (2025 gross margin ~42%, EBIT margin ~17.8%, net margin ~13.5%), and the balance sheet is conservatively levered (debt-to-equity ~0.10). Offsetting this, 2025 revenue declined (-3.2%), margins have compressed versus 2022–2023, and cash generation weakened with free cash flow down ~59.8% YoY and only ~0.33x net income.
Income Statement
72PositiveBalance Sheet
84Very PositiveCash Flow
56Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.37B | 1.36B | 1.41B | 1.37B | 990.04M | 997.79M |
| Gross Profit | 563.79M | 573.90M | 611.30M | 621.13M | 434.70M | 448.67M |
| EBITDA | 364.94M | 390.30M | 391.25M | 434.82M | 311.36M | 304.65M |
| Net Income | 164.63M | 183.44M | 195.08M | 228.91M | 187.75M | 161.75M |
Balance Sheet | ||||||
| Total Assets | 2.97B | 3.02B | 2.88B | 2.92B | 2.72B | 2.51B |
| Cash, Cash Equivalents and Short-Term Investments | 1.40B | 1.49B | 1.54B | 1.55B | 1.68B | 1.78B |
| Total Debt | 249.02M | 237.74M | 218.01M | 200.80M | 196.16M | 178.65M |
| Total Liabilities | 648.55M | 612.92M | 554.76M | 544.38M | 424.68M | 378.11M |
| Stockholders Equity | 2.32B | 2.40B | 2.32B | 2.36B | 2.27B | 2.11B |
Cash Flow | ||||||
| Free Cash Flow | 143.82M | 112.58M | 354.36M | 286.02M | 148.29M | 189.18M |
| Operating Cash Flow | 332.50M | 339.41M | 354.36M | 372.57M | 273.41M | 249.39M |
| Investing Cash Flow | -211.08M | -460.60M | 245.36M | -654.10M | -464.77M | -578.51M |
| Financing Cash Flow | -202.13M | -132.87M | -292.30M | -204.01M | -165.43M | 1.19B |
Chaoju Eye Care Holdings Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2219, the sentiment is Negative. The current price of 2.36 is below the 20-day moving average (MA) of 2.38, below the 50-day MA of 2.44, and below the 200-day MA of 2.51, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 43.91 is Neutral, neither overbought nor oversold. The STOCH value of 27.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2219.
Chaoju Eye Care Holdings Ltd. Peers Comparison
Overall Rating
- HK:221974Outperform
HK:330966Neutral
HK:184663Neutral
HK:386954Neutral
HK:663948Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2219 | 74Outperform | HKD 1.66B | 8.34 | 6.97% | 10.27% | 3.85% | -1.23% |
| HK:3309 | 66Neutral | HKD 1.05B | 10.10 | 5.57% | 2.35% | 4.75% | ― |
| HK:1846 | 63Neutral | HKD 703.50M | 285.71 | 0.20% | 2.00% | 20.54% | -96.74% |
| HK:3869 | 54Neutral | HKD 467.79M | -143.62 | -0.41% | ― | 3.16% | -101.02% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:6639 | 48Neutral | HKD 1.03B | 31.06 | 1.27% | ― | ― | ― |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2219 | Chaoju Eye Care Holdings Ltd. | 2.36 | 0.01 | 0.43% | |
| HK:1846 | EuroEyes International Eye Clinic Limited | 2.20 | -1.09 | -33.17% | |
| HK:3309 | C-MER Eye Care Holdings Limited | 0.85 | -0.91 | -51.81% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.38 | -2.61 | -43.49% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:6639 | Arrail Group Ltd. | 1.83 | -0.09 | -4.74% |
Chaoju Eye Care Holdings Ltd. Corporate Events
Chaoju Eye Care Posts Higher Revenue but Sharply Lower Profits in Interim Results
Chaoju Eye Care Holdings reported a modest 1.8% year-on-year increase in revenue to RMB710.7 million for the six months ended June 30, 2026, but saw profitability weaken as gross profit fell 3.5% and margins tightened. Net profit declined 16.1% to RM...
Chaoju Eye Care Announces Resignation of Non-Executive Director Zhang Li
Chaoju Eye Care Holdings announced that non-executive director Zhang Li has resigned from the board, effective August 28, 2026, citing a desire to pursue personal commitments and interests. The company emphasized that Zhang had no disagreements with...
Chaoju Eye Care Details Board and Committee Structure to Bolster Governance
Chaoju Eye Care Holdings Limited announced the composition of its board of directors, detailing the mix of executive, non‑executive, and independent non‑executive members and their respective leadership roles. The company also formalised...
Chaoju Eye Care Sets August Board Meeting to Approve Interim Results and Mull Dividend
Chaoju Eye Care Holdings Limited has scheduled a board meeting for August 28, 2026 to review and approve the group’s interim results for the six months ended June 30, 2026 and to authorize their publication. The board will also consider whether...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 06, 2026